Health in Indonesia 1,216 indicators covering health for Indonesia. IndicatorLatest Year10-yr change Rank Estimated number of children needing antiretroviral therapy based on 8,000 2025 down 4.8% 23rd Prevalence of severe wasting, weight for height 2.1% 2023 down 68.7% 14th Physical activity policies for activie societies 10 2023 unchanged 111th Physical activity policies focused on active systems 10 2023 down 50.0% 99th Midwifery personnel 347,466 2024 up 211.0% 1st Number of deaths from malaria who 1,138 2024 down 39.9% 36th Death rate from malaria 0.4014 2024 down 45.2% 53rd Incidence of malaria 2.23 2024 down 50.3% 58th Share of one year olds who received the final dose of pneumococcal vac 70 2024 — 123rd Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 70 2024 — 123rd Estimated antiretroviral therapy coverage among children 55 2025 up 71.9% 38th Death rate from poisonings 0.2 2021 down 50.0% 136th Mortality rate attributed to cardiovascular disease, cancer, diabetes 21.9 % 2021 down 15.8% 55th Mortality rate attributed to unintentional poisonings, by sex 0.2 per 100,000 people 2021 down 50.0% 120th Suicide mortality rate, by sex 1.2 per 100,000 people 2021 down 33.3% 162nd Share of deaths registered 43.85 2019 — 137th Prevalence of stunting, height for age 22.0% 2023 down 39.6% 40th Affordability - percentage of GDP per capita required to purchase 4.98 2022 up 4.8% 70th Health expenditure and financing per capita 380.24 2024 up 26.2% 58th Road deaths over the long term 29,472 2018 up 46.0% 4th Japanese encephalitis - number of reported cases 10 2025 down 75.0% 9th Malaria cases reported 543,625 2024 up 115.7% 32nd Deaths and missing persons due to natural disasters 0.11 2023 down 45.0% 91st Mean systolic blood pressure 124.9 2009 up 0.8% 103rd Mean fasting blood glucose (mmol/l) 5 2009 down 2.0% 156th Number of pregnant women living with HIV who received antiretrovirals 2,082 2025 up 111.2% 33rd Hiv expenditure 156.88 million 2022 up 80.3% 19th Number of new leprosy cases with G2D among children 32 2024 down 48.4% 4th Neonates protected at birth against neonatal tetanus (PAB) 83.0% 2022 down 2.4% 74th Prevalence of overweight, weight for height 4.3% 2023 down 62.6% 51st Most sold brand of cigarettes - price in currency reported 30,625 2020 up 133.3% 3rd Most sold brand of cigarettes - taxes as a % of price - total tax 0.6% 2020 up 14.8% 76th Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.0% 2020 — 109th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 33rd Most sold brand of cigarettes - taxes as a % of price - other taxes 0.1% 2020 — 11th Most sold brand of cigarettes - taxes as a % of price - value added 0.1% 2020 up 12.5% 123rd Most sold brand of cigarettes - taxes as a % of price - specific 0.5% 2020 up 4.3% 22nd Most sold brand of cigarettes - price in US$ at official exchange 2.09 2020 up 42.2% 112th Number healthy diet unaffordable 123.40 million 2024 down 6.4% 5th Import of environmentally sound technologies 13.03 billion 2020 up 49.7% 27th Most sold brand of cigarettes - price in PPP$ 6.4 2020 up 62.8% 83rd Export of environmentally sound technologies 3.82 billion 2020 down 10.5% 37th Pcv3 number unvaccinated 3.07 million 2023 down 33.9% 3rd Reported number of human rabies deaths 122 2024 up 15.1% 6th Proportion of births delivered in a health facility (Facility births) 80.4% 2020 up 27.2% 103rd Number of non-autochthonous leprosy cases 0 2024 — 47th Prevalence of wasting, weight for height, female 7.5% 2023 down 40.9% 16th Prevalence of wasting, weight for height, male 9.2% 2023 down 35.2% 17th Number reported cases of cholera 1,007 2008 up 1,425.8% 13th Population with basic handwashing facilities at home 76.9% 2024 up 11.0% 45th Prevalence of severe wasting, weight for height, female 1.8% 2023 down 71.0% 18th Prevalence of severe wasting, weight for height, male 2.4% 2023 down 66.7% 15th Prevalence of overweight, weight for height, female 4.0% 2023 down 64.6% 42nd Prevalence of overweight, weight for height, male 4.5% 2023 down 61.9% 43rd HPV immunization coverage estimates among primary target cohort (9-14) 83.0% 2025 up 2,666.7% 32nd Prevalence of underweight, weight for age, female 15.2% 2023 down 21.6% 25th Prevalence of underweight, weight for age, male 16.7% 2023 down 18.5% 25th Prevalence of stunting, height for age, female 20.5% 2023 down 42.3% 39th Prevalence of stunting, height for age, male 23.4% 2023 down 37.1% 42nd Life expectancy at birth oecd 67.6 2022 down 1.7% 47th ← Previous Page 16 of 21 Next →